Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Pasithea Therapeutics stock

Learn how to easily invest in Pasithea Therapeutics stock.

Pasithea Therapeutics Corp is a biotechnology business based in the US. Pasithea Therapeutics shares (KTTA) are listed on the NASDAQ and all prices are listed in US Dollars. Pasithea Therapeutics employs 3 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Pasithea Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KTTA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Pasithea Therapeutics stock price (NASDAQ: KTTA)

Use our graph to track the performance of KTTA stocks over time.

Pasithea Therapeutics shares at a glance

Information last updated 2022-06-27.
Latest market close$1.00
52-week range$0.81 - $5.60
50-day moving average $1.04
200-day moving average $1.75
Wall St. target price$2.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.23

Buy Pasithea Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pasithea Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pasithea Therapeutics price performance over time

Historical closes compared with the close of $1 from 2022-07-01

1 week (2022-06-24) 2.66%
1 month (2022-06-01) 3.09%
3 months (2022-04-01) -22.48%
6 months (2021-12-31) -43.50%
1 year (2021-06-28) N/A
2 years (2020-06-28) N/A
3 years (2019-06-28) N/A
5 years (2017-06-28) N/A

Pasithea Therapeutics financials

Revenue TTM $28,720
Gross profit TTM $-2,213
Return on assets TTM -10.52%
Return on equity TTM -8.41%
Profit margin 0%
Book value $2.17
Market capitalisation $22.7 million

TTM: trailing 12 months

Pasithea Therapeutics share dividends

We're not expecting Pasithea Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

Pasithea Therapeutics overview

Pasithea Therapeutics Corp. , a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida. .

Frequently asked questions

What percentage of Pasithea Therapeutics is owned by insiders or institutions?
Currently 10.484% of Pasithea Therapeutics shares are held by insiders and 10.369% by institutions.
How many people work for Pasithea Therapeutics?
Latest data suggests 3 work at Pasithea Therapeutics.
When does the fiscal year end for Pasithea Therapeutics?
Pasithea Therapeutics's fiscal year ends in December.
Where is Pasithea Therapeutics based?
Pasithea Therapeutics's address is: 1111 Lincoln Road, Miami Beach, FL, United States, 33139
What is Pasithea Therapeutics's ISIN number?
Pasithea Therapeutics's international securities identification number is: US70261F1030

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site